新疆新鑫礦業(03833.HK):國資委就公司H股流通向控股股東作出的批覆
格隆匯10月22日丨新疆新鑫礦業(03833.HK)宣佈,公司已於2021年10月21日獲新疆有色金屬工業(集團)有限責任公司("新疆有色")(為公司發起人之一及控股股東)通知,其已收到新疆維吾爾自治區國有資產監督管理委員會("國資委")的批覆,新疆有色可自主決策將其於公司的部分內資股轉換為公司H股的有關事宜。
據董事會所知,部分其他內資股持有人("內資股股東")亦可能擬將其內資股轉換為H股。待(其中包括)公司向中國及香港相關監管機構申請並取得必要監管批准後,公司可採納及實施H股流通方案,據此,內資股股東的經轉換H股可於香港聯合交易所有限公司上市及買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.